Report Overview
Immuno-oncology therapy is a type of cancer treatment that harnesses the body's immune system to target and destroy cancer cells. It includes therapies such as immune checkpoint inhibitors, cancer vaccines, and adoptive T cell therapies.
The global Immuno-oncology Therapy market size was estimated at USD 1233 million in 2023 and is projected to reach USD 1832.36 million by 2032, exhibiting a CAGR of 4.50% during the forecast period.
North America Immuno-oncology Therapy market size was estimated at USD 346.55 million in 2023, at a CAGR of 3.86% during the forecast period of 2025 through 2032.
This report provides a deep insight into the global Immuno-oncology Therapy market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Immuno-oncology Therapy Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Immuno-oncology Therapy market in any manner.
Global Immuno-oncology Therapy Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli-Lilly
Roche
GlaxoSmithKline
Janssen Biotech
Merck
Novartis
Pfizer
Sanofi
Spectrum Pharmaceuticals
Takeda
BioNTech SE
Allogene Therapeutics
IMAB-I-Mab Biopharma Co.
Ltd.
Arcus Biosciences
Gritstone Oncology
Autolus Therapeutics
Rubius Therapeutics
Market Segmentation (by Type)
Monoclonal Antibodies
Immune Checkpoint Inhibitors
Immune System Modulators
Cancer Vaccines
Market Segmentation (by Application)
Hospitals
Ambulatory Surgical Center
Others
Geographic Segmentation
� North America (USA, Canada, Mexico)
� Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
� Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
� South America (Brazil, Argentina, Columbia, Rest of South America)
� The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
� Industry drivers, restraints, and opportunities covered in the study
� Neutral perspective on the market performance
� Recent industry trends and developments
� Competitive landscape & strategies of key players
� Potential & niche segments and regions exhibiting promising growth covered
� Historical, current, and projected market size, in terms of value
� In-depth analysis of the Immuno-oncology Therapy Market
� Overview of the regional outlook of the Immuno-oncology Therapy Market:
Key Reasons to Buy this Report:
� Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
� This enables you to anticipate market changes to remain ahead of your competitors
� You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
� The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
� Provision of market value data for each segment and sub-segment
� Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
� Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
� Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
� Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
� The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
� Includes in-depth analysis of the market from various perspectives through Porter�s five forces analysis
� Provides insight into the market through Value Chain
� Market dynamics scenario, along with growth opportunities of the market in the years to come
� 6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Immuno-oncology Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region from the consumer side and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Immuno-oncology Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region during the forecast period.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment during the forecast period.
Chapter 13 is the main points and conclusions of the report.
TABLE OF CONTENTS
Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Immuno-oncology Therapy
1.2 Key Market Segments
1.2.1 Immuno-oncology Therapy Segment by Type
1.2.2 Immuno-oncology Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Immuno-oncology Therapy Market Overview
2.1 Global Market Overview
2.1.1 Global Immuno-oncology Therapy Market Size (M USD) Estimates and Forecasts (2019-2032)
2.1.2 Global Immuno-oncology Therapy Sales Estimates and Forecasts (2019-2032)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Immuno-oncology Therapy Market Competitive Landscape
3.1 Global Immuno-oncology Therapy Sales by Manufacturers (2019-2025)
3.2 Global Immuno-oncology Therapy Revenue Market Share by Manufacturers (2019-2025)
3.3 Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Immuno-oncology Therapy Average Price by Manufacturers (2019-2025)
3.5 Manufacturers Immuno-oncology Therapy Sales Sites, Area Served, Product Type
3.6 Immuno-oncology Therapy Market Competitive Situation and Trends
3.6.1 Immuno-oncology Therapy Market Concentration Rate
3.6.2 Global 5 and 10 Largest Immuno-oncology Therapy Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Immuno-oncology Therapy Industry Chain Analysis
4.1 Immuno-oncology Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Immuno-oncology Therapy Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Immuno-oncology Therapy Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Immuno-oncology Therapy Sales Market Share by Type (2019-2025)
6.3 Global Immuno-oncology Therapy Market Size Market Share by Type (2019-2025)
6.4 Global Immuno-oncology Therapy Price by Type (2019-2025)
7 Immuno-oncology Therapy Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Immuno-oncology Therapy Market Sales by Application (2019-2025)
7.3 Global Immuno-oncology Therapy Market Size (M USD) by Application (2019-2025)
7.4 Global Immuno-oncology Therapy Sales Growth Rate by Application (2019-2025)
8 Immuno-oncology Therapy Market Consumption by Region
8.1 Global Immuno-oncology Therapy Sales by Region
8.1.1 Global Immuno-oncology Therapy Sales by Region
8.1.2 Global Immuno-oncology Therapy Sales Market Share by Region
8.2 North America
8.2.1 North America Immuno-oncology Therapy Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Immuno-oncology Therapy Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Immuno-oncology Therapy Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Immuno-oncology Therapy Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Immuno-oncology Therapy Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Immuno-oncology Therapy Market Production by Region
9.1 Global Production of Immuno-oncology Therapy by Region (2019-2025)
9.2 Global Immuno-oncology Therapy Revenue Market Share by Region (2019-2025)
9.3 Global Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.4 North America Immuno-oncology Therapy Production
9.4.1 North America Immuno-oncology Therapy Production Growth Rate (2019-2025)
9.4.2 North America Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.5 Europe Immuno-oncology Therapy Production
9.5.1 Europe Immuno-oncology Therapy Production Growth Rate (2019-2025)
9.5.2 Europe Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.6 Japan Immuno-oncology Therapy Production (2019-2025)
9.6.1 Japan Immuno-oncology Therapy Production Growth Rate (2019-2025)
9.6.2 Japan Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2019-2025)
9.7 China Immuno-oncology Therapy Production (2019-2025)
9.7.1 China Immuno-oncology Therapy Production Growth Rate (2019-2025)
9.7.2 China Immuno-oncology Therapy Production, Revenue, Price and Gross Margin (2019-2025)
10 Key Companies Profile
10.1 Amgen
10.1.1 Amgen Immuno-oncology Therapy Basic Information
10.1.2 Amgen Immuno-oncology Therapy Product Overview
10.1.3 Amgen Immuno-oncology Therapy Product Market Performance
10.1.4 Amgen Business Overview
10.1.5 Amgen Immuno-oncology Therapy SWOT Analysis
10.1.6 Amgen Recent Developments
10.2 AstraZeneca
10.2.1 AstraZeneca Immuno-oncology Therapy Basic Information
10.2.2 AstraZeneca Immuno-oncology Therapy Product Overview
10.2.3 AstraZeneca Immuno-oncology Therapy Product Market Performance
10.2.4 AstraZeneca Business Overview
10.2.5 AstraZeneca Immuno-oncology Therapy SWOT Analysis
10.2.6 AstraZeneca Recent Developments
10.3 Bristol-Myers Squibb
10.3.1 Bristol-Myers Squibb Immuno-oncology Therapy Basic Information
10.3.2 Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
10.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Product Market Performance
10.3.4 Bristol-Myers Squibb Immuno-oncology Therapy SWOT Analysis
10.3.5 Bristol-Myers Squibb Business Overview
10.3.6 Bristol-Myers Squibb Recent Developments
10.4 Eli-Lilly
10.4.1 Eli-Lilly Immuno-oncology Therapy Basic Information
10.4.2 Eli-Lilly Immuno-oncology Therapy Product Overview
10.4.3 Eli-Lilly Immuno-oncology Therapy Product Market Performance
10.4.4 Eli-Lilly Business Overview
10.4.5 Eli-Lilly Recent Developments
10.5 Roche
10.5.1 Roche Immuno-oncology Therapy Basic Information
10.5.2 Roche Immuno-oncology Therapy Product Overview
10.5.3 Roche Immuno-oncology Therapy Product Market Performance
10.5.4 Roche Business Overview
10.5.5 Roche Recent Developments
10.6 GlaxoSmithKline
10.6.1 GlaxoSmithKline Immuno-oncology Therapy Basic Information
10.6.2 GlaxoSmithKline Immuno-oncology Therapy Product Overview
10.6.3 GlaxoSmithKline Immuno-oncology Therapy Product Market Performance
10.6.4 GlaxoSmithKline Business Overview
10.6.5 GlaxoSmithKline Recent Developments
10.7 Janssen Biotech
10.7.1 Janssen Biotech Immuno-oncology Therapy Basic Information
10.7.2 Janssen Biotech Immuno-oncology Therapy Product Overview
10.7.3 Janssen Biotech Immuno-oncology Therapy Product Market Performance
10.7.4 Janssen Biotech Business Overview
10.7.5 Janssen Biotech Recent Developments
10.8 Merck
10.8.1 Merck Immuno-oncology Therapy Basic Information
10.8.2 Merck Immuno-oncology Therapy Product Overview
10.8.3 Merck Immuno-oncology Therapy Product Market Performance
10.8.4 Merck Business Overview
10.8.5 Merck Recent Developments
10.9 Novartis
10.9.1 Novartis Immuno-oncology Therapy Basic Information
10.9.2 Novartis Immuno-oncology Therapy Product Overview
10.9.3 Novartis Immuno-oncology Therapy Product Market Performance
10.9.4 Novartis Business Overview
10.9.5 Novartis Recent Developments
10.10 Pfizer
10.10.1 Pfizer Immuno-oncology Therapy Basic Information
10.10.2 Pfizer Immuno-oncology Therapy Product Overview
10.10.3 Pfizer Immuno-oncology Therapy Product Market Performance
10.10.4 Pfizer Business Overview
10.10.5 Pfizer Recent Developments
10.11 Sanofi
10.11.1 Sanofi Immuno-oncology Therapy Basic Information
10.11.2 Sanofi Immuno-oncology Therapy Product Overview
10.11.3 Sanofi Immuno-oncology Therapy Product Market Performance
10.11.4 Sanofi Business Overview
10.11.5 Sanofi Recent Developments
10.12 Spectrum Pharmaceuticals
10.12.1 Spectrum Pharmaceuticals Immuno-oncology Therapy Basic Information
10.12.2 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
10.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Product Market Performance
10.12.4 Spectrum Pharmaceuticals Business Overview
10.12.5 Spectrum Pharmaceuticals Recent Developments
10.13 Takeda
10.13.1 Takeda Immuno-oncology Therapy Basic Information
10.13.2 Takeda Immuno-oncology Therapy Product Overview
10.13.3 Takeda Immuno-oncology Therapy Product Market Performance
10.13.4 Takeda Business Overview
10.13.5 Takeda Recent Developments
10.14 BioNTech SE
10.14.1 BioNTech SE Immuno-oncology Therapy Basic Information
10.14.2 BioNTech SE Immuno-oncology Therapy Product Overview
10.14.3 BioNTech SE Immuno-oncology Therapy Product Market Performance
10.14.4 BioNTech SE Business Overview
10.14.5 BioNTech SE Recent Developments
10.15 Allogene Therapeutics
10.15.1 Allogene Therapeutics Immuno-oncology Therapy Basic Information
10.15.2 Allogene Therapeutics Immuno-oncology Therapy Product Overview
10.15.3 Allogene Therapeutics Immuno-oncology Therapy Product Market Performance
10.15.4 Allogene Therapeutics Business Overview
10.15.5 Allogene Therapeutics Recent Developments
10.16 IMAB-I-Mab Biopharma Co.
10.16.1 IMAB-I-Mab Biopharma Co. Immuno-oncology Therapy Basic Information
10.16.2 IMAB-I-Mab Biopharma Co. Immuno-oncology Therapy Product Overview
10.16.3 IMAB-I-Mab Biopharma Co. Immuno-oncology Therapy Product Market Performance
10.16.4 IMAB-I-Mab Biopharma Co. Business Overview
10.16.5 IMAB-I-Mab Biopharma Co. Recent Developments
10.17 Ltd.
10.17.1 Ltd. Immuno-oncology Therapy Basic Information
10.17.2 Ltd. Immuno-oncology Therapy Product Overview
10.17.3 Ltd. Immuno-oncology Therapy Product Market Performance
10.17.4 Ltd. Business Overview
10.17.5 Ltd. Recent Developments
10.18 Arcus Biosciences
10.18.1 Arcus Biosciences Immuno-oncology Therapy Basic Information
10.18.2 Arcus Biosciences Immuno-oncology Therapy Product Overview
10.18.3 Arcus Biosciences Immuno-oncology Therapy Product Market Performance
10.18.4 Arcus Biosciences Business Overview
10.18.5 Arcus Biosciences Recent Developments
10.19 Gritstone Oncology
10.19.1 Gritstone Oncology Immuno-oncology Therapy Basic Information
10.19.2 Gritstone Oncology Immuno-oncology Therapy Product Overview
10.19.3 Gritstone Oncology Immuno-oncology Therapy Product Market Performance
10.19.4 Gritstone Oncology Business Overview
10.19.5 Gritstone Oncology Recent Developments
10.20 Autolus Therapeutics
10.20.1 Autolus Therapeutics Immuno-oncology Therapy Basic Information
10.20.2 Autolus Therapeutics Immuno-oncology Therapy Product Overview
10.20.3 Autolus Therapeutics Immuno-oncology Therapy Product Market Performance
10.20.4 Autolus Therapeutics Business Overview
10.20.5 Autolus Therapeutics Recent Developments
10.21 Rubius Therapeutics
10.21.1 Rubius Therapeutics Immuno-oncology Therapy Basic Information
10.21.2 Rubius Therapeutics Immuno-oncology Therapy Product Overview
10.21.3 Rubius Therapeutics Immuno-oncology Therapy Product Market Performance
10.21.4 Rubius Therapeutics Business Overview
10.21.5 Rubius Therapeutics Recent Developments
11 Immuno-oncology Therapy Market Forecast by Region
11.1 Global Immuno-oncology Therapy Market Size Forecast
11.2 Global Immuno-oncology Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Immuno-oncology Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region
11.2.4 South America Immuno-oncology Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Consumption of Immuno-oncology Therapy by Country
12 Forecast Market by Type and by Application (2025-2032)
12.1 Global Immuno-oncology Therapy Market Forecast by Type (2025-2032)
12.1.1 Global Forecasted Sales of Immuno-oncology Therapy by Type (2025-2032)
12.1.2 Global Immuno-oncology Therapy Market Size Forecast by Type (2025-2032)
12.1.3 Global Forecasted Price of Immuno-oncology Therapy by Type (2025-2032)
12.2 Global Immuno-oncology Therapy Market Forecast by Application (2025-2032)
12.2.1 Global Immuno-oncology Therapy Sales (K MT) Forecast by Application
12.2.2 Global Immuno-oncology Therapy Market Size (M USD) Forecast by Application (2025-2032)
13 Conclusion and Key Findings
LIST OF TABLES & FIGURES
List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Immuno-oncology Therapy Market Size Comparison by Region (M USD)
Table 5. Global Immuno-oncology Therapy Sales (K MT) by Manufacturers (2019-2025)
Table 6. Global Immuno-oncology Therapy Sales Market Share by Manufacturers (2019-2025)
Table 7. Global Immuno-oncology Therapy Revenue (M USD) by Manufacturers (2019-2025)
Table 8. Global Immuno-oncology Therapy Revenue Share by Manufacturers (2019-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immuno-oncology Therapy as of 2022)
Table 10. Global Market Immuno-oncology Therapy Average Price (USD/MT) of Key Manufacturers (2019-2025)
Table 11. Manufacturers Immuno-oncology Therapy Sales Sites and Area Served
Table 12. Manufacturers Immuno-oncology Therapy Product Type
Table 13. Global Immuno-oncology Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Industry Chain Map of Immuno-oncology Therapy
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Immuno-oncology Therapy Market Challenges
Table 22. Global Immuno-oncology Therapy Sales by Type (K MT)
Table 23. Global Immuno-oncology Therapy Market Size by Type (M USD)
Table 24. Global Immuno-oncology Therapy Sales (K MT) by Type (2019-2025)
Table 25. Global Immuno-oncology Therapy Sales Market Share by Type (2019-2025)
Table 26. Global Immuno-oncology Therapy Market Size (M USD) by Type (2019-2025)
Table 27. Global Immuno-oncology Therapy Market Size Share by Type (2019-2025)
Table 28. Global Immuno-oncology Therapy Price (USD/MT) by Type (2019-2025)
Table 29. Global Immuno-oncology Therapy Sales (K MT) by Application
Table 30. Global Immuno-oncology Therapy Market Size by Application
Table 31. Global Immuno-oncology Therapy Sales by Application (2019-2025) & (K MT)
Table 32. Global Immuno-oncology Therapy Sales Market Share by Application (2019-2025)
Table 33. Global Immuno-oncology Therapy Sales by Application (2019-2025) & (M USD)
Table 34. Global Immuno-oncology Therapy Market Share by Application (2019-2025)
Table 35. Global Immuno-oncology Therapy Sales Growth Rate by Application (2019-2025)
Table 36. Global Immuno-oncology Therapy Sales by Region (2019-2025) & (K MT)
Table 37. Global Immuno-oncology Therapy Sales Market Share by Region (2019-2025)
Table 38. North America Immuno-oncology Therapy Sales by Country (2019-2025) & (K MT)
Table 39. Europe Immuno-oncology Therapy Sales by Country (2019-2025) & (K MT)
Table 40. Asia Pacific Immuno-oncology Therapy Sales by Region (2019-2025) & (K MT)
Table 41. South America Immuno-oncology Therapy Sales by Country (2019-2025) & (K MT)
Table 42. Middle East and Africa Immuno-oncology Therapy Sales by Region (2019-2025) & (K MT)
Table 43. Global Immuno-oncology Therapy Production (K MT) by Region (2019-2025)
Table 44. Global Immuno-oncology Therapy Revenue (US$ Million) by Region (2019-2025)
Table 45. Global Immuno-oncology Therapy Revenue Market Share by Region (2019-2025)
Table 46. Global Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 47. North America Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 48. Europe Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 49. Japan Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 50. China Immuno-oncology Therapy Production (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2025)
Table 51. Amgen Immuno-oncology Therapy Basic Information
Table 52. Amgen Immuno-oncology Therapy Product Overview
Table 53. Amgen Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 54. Amgen Business Overview
Table 55. Amgen Immuno-oncology Therapy SWOT Analysis
Table 56. Amgen Recent Developments
Table 57. AstraZeneca Immuno-oncology Therapy Basic Information
Table 58. AstraZeneca Immuno-oncology Therapy Product Overview
Table 59. AstraZeneca Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 60. AstraZeneca Business Overview
Table 61. AstraZeneca Immuno-oncology Therapy SWOT Analysis
Table 62. AstraZeneca Recent Developments
Table 63. Bristol-Myers Squibb Immuno-oncology Therapy Basic Information
Table 64. Bristol-Myers Squibb Immuno-oncology Therapy Product Overview
Table 65. Bristol-Myers Squibb Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 66. Bristol-Myers Squibb Immuno-oncology Therapy SWOT Analysis
Table 67. Bristol-Myers Squibb Business Overview
Table 68. Bristol-Myers Squibb Recent Developments
Table 69. Eli-Lilly Immuno-oncology Therapy Basic Information
Table 70. Eli-Lilly Immuno-oncology Therapy Product Overview
Table 71. Eli-Lilly Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 72. Eli-Lilly Business Overview
Table 73. Eli-Lilly Recent Developments
Table 74. Roche Immuno-oncology Therapy Basic Information
Table 75. Roche Immuno-oncology Therapy Product Overview
Table 76. Roche Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 77. Roche Business Overview
Table 78. Roche Recent Developments
Table 79. GlaxoSmithKline Immuno-oncology Therapy Basic Information
Table 80. GlaxoSmithKline Immuno-oncology Therapy Product Overview
Table 81. GlaxoSmithKline Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 82. GlaxoSmithKline Business Overview
Table 83. GlaxoSmithKline Recent Developments
Table 84. Janssen Biotech Immuno-oncology Therapy Basic Information
Table 85. Janssen Biotech Immuno-oncology Therapy Product Overview
Table 86. Janssen Biotech Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 87. Janssen Biotech Business Overview
Table 88. Janssen Biotech Recent Developments
Table 89. Merck Immuno-oncology Therapy Basic Information
Table 90. Merck Immuno-oncology Therapy Product Overview
Table 91. Merck Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 92. Merck Business Overview
Table 93. Merck Recent Developments
Table 94. Novartis Immuno-oncology Therapy Basic Information
Table 95. Novartis Immuno-oncology Therapy Product Overview
Table 96. Novartis Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 97. Novartis Business Overview
Table 98. Novartis Recent Developments
Table 99. Pfizer Immuno-oncology Therapy Basic Information
Table 100. Pfizer Immuno-oncology Therapy Product Overview
Table 101. Pfizer Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 102. Pfizer Business Overview
Table 103. Pfizer Recent Developments
Table 104. Sanofi Immuno-oncology Therapy Basic Information
Table 105. Sanofi Immuno-oncology Therapy Product Overview
Table 106. Sanofi Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 107. Sanofi Business Overview
Table 108. Sanofi Recent Developments
Table 109. Spectrum Pharmaceuticals Immuno-oncology Therapy Basic Information
Table 110. Spectrum Pharmaceuticals Immuno-oncology Therapy Product Overview
Table 111. Spectrum Pharmaceuticals Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 112. Spectrum Pharmaceuticals Business Overview
Table 113. Spectrum Pharmaceuticals Recent Developments
Table 114. Takeda Immuno-oncology Therapy Basic Information
Table 115. Takeda Immuno-oncology Therapy Product Overview
Table 116. Takeda Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 117. Takeda Business Overview
Table 118. Takeda Recent Developments
Table 119. BioNTech SE Immuno-oncology Therapy Basic Information
Table 120. BioNTech SE Immuno-oncology Therapy Product Overview
Table 121. BioNTech SE Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 122. BioNTech SE Business Overview
Table 123. BioNTech SE Recent Developments
Table 124. Allogene Therapeutics Immuno-oncology Therapy Basic Information
Table 125. Allogene Therapeutics Immuno-oncology Therapy Product Overview
Table 126. Allogene Therapeutics Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 127. Allogene Therapeutics Business Overview
Table 128. Allogene Therapeutics Recent Developments
Table 129. IMAB-I-Mab Biopharma Co. Immuno-oncology Therapy Basic Information
Table 130. IMAB-I-Mab Biopharma Co. Immuno-oncology Therapy Product Overview
Table 131. IMAB-I-Mab Biopharma Co. Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 132. IMAB-I-Mab Biopharma Co. Business Overview
Table 133. IMAB-I-Mab Biopharma Co. Recent Developments
Table 134. Ltd. Immuno-oncology Therapy Basic Information
Table 135. Ltd. Immuno-oncology Therapy Product Overview
Table 136. Ltd. Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 137. Ltd. Business Overview
Table 138. Ltd. Recent Developments
Table 139. Arcus Biosciences Immuno-oncology Therapy Basic Information
Table 140. Arcus Biosciences Immuno-oncology Therapy Product Overview
Table 141. Arcus Biosciences Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 142. Arcus Biosciences Business Overview
Table 143. Arcus Biosciences Recent Developments
Table 144. Gritstone Oncology Immuno-oncology Therapy Basic Information
Table 145. Gritstone Oncology Immuno-oncology Therapy Product Overview
Table 146. Gritstone Oncology Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 147. Gritstone Oncology Business Overview
Table 148. Gritstone Oncology Recent Developments
Table 149. Autolus Therapeutics Immuno-oncology Therapy Basic Information
Table 150. Autolus Therapeutics Immuno-oncology Therapy Product Overview
Table 151. Autolus Therapeutics Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 152. Autolus Therapeutics Business Overview
Table 153. Autolus Therapeutics Recent Developments
Table 154. Rubius Therapeutics Immuno-oncology Therapy Basic Information
Table 155. Rubius Therapeutics Immuno-oncology Therapy Product Overview
Table 156. Rubius Therapeutics Immuno-oncology Therapy Sales (K MT), Revenue (M USD), Price (USD/MT) and Gross Margin (2019-2025)
Table 157. Rubius Therapeutics Business Overview
Table 158. Rubius Therapeutics Recent Developments
Table 159. Global Immuno-oncology Therapy Sales Forecast by Region (2025-2032) & (K MT)
Table 160. Global Immuno-oncology Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 161. North America Immuno-oncology Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 162. North America Immuno-oncology Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 163. Europe Immuno-oncology Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 164. Europe Immuno-oncology Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 165. Asia Pacific Immuno-oncology Therapy Sales Forecast by Region (2025-2032) & (K MT)
Table 166. Asia Pacific Immuno-oncology Therapy Market Size Forecast by Region (2025-2032) & (M USD)
Table 167. South America Immuno-oncology Therapy Sales Forecast by Country (2025-2032) & (K MT)
Table 168. South America Immuno-oncology Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 169. Middle East and Africa Immuno-oncology Therapy Consumption Forecast by Country (2025-2032) & (Units)
Table 170. Middle East and Africa Immuno-oncology Therapy Market Size Forecast by Country (2025-2032) & (M USD)
Table 171. Global Immuno-oncology Therapy Sales Forecast by Type (2025-2032) & (K MT)
Table 172. Global Immuno-oncology Therapy Market Size Forecast by Type (2025-2032) & (M USD)
Table 173. Global Immuno-oncology Therapy Price Forecast by Type (2025-2032) & (USD/MT)
Table 174. Global Immuno-oncology Therapy Sales (K MT) Forecast by Application (2025-2032)
Table 175. Global Immuno-oncology Therapy Market Size Forecast by Application (2025-2032) & (M USD)
List of Figures
Figure 1. Product Picture of Immuno-oncology Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Immuno-oncology Therapy Market Size (M USD), 2019-2032
Figure 5. Global Immuno-oncology Therapy Market Size (M USD) (2019-2032)
Figure 6. Global Immuno-oncology Therapy Sales (K MT) & (2019-2032)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Immuno-oncology Therapy Market Size by Country (M USD)
Figure 11. Immuno-oncology Therapy Sales Share by Manufacturers in 2023
Figure 12. Global Immuno-oncology Therapy Revenue Share by Manufacturers in 2023
Figure 13. Immuno-oncology Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2023
Figure 14. Global Market Immuno-oncology Therapy Average Price (USD/MT) of Key Manufacturers in 2023
Figure 15. The Global 5 and 10 Largest Players: Market Share by Immuno-oncology Therapy Revenue in 2023
Figure 16. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 17. Global Immuno-oncology Therapy Market Share by Type
Figure 18. Sales Market Share of Immuno-oncology Therapy by Type (2019-2025)
Figure 19. Sales Market Share of Immuno-oncology Therapy by Type in 2023
Figure 20. Market Size Share of Immuno-oncology Therapy by Type (2019-2025)
Figure 21. Market Size Market Share of Immuno-oncology Therapy by Type in 2023
Figure 22. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 23. Global Immuno-oncology Therapy Market Share by Application
Figure 24. Global Immuno-oncology Therapy Sales Market Share by Application (2019-2025)
Figure 25. Global Immuno-oncology Therapy Sales Market Share by Application in 2023
Figure 26. Global Immuno-oncology Therapy Market Share by Application (2019-2025)
Figure 27. Global Immuno-oncology Therapy Market Share by Application in 2023
Figure 28. Global Immuno-oncology Therapy Sales Growth Rate by Application (2019-2025)
Figure 29. Global Immuno-oncology Therapy Sales Market Share by Region (2019-2025)
Figure 30. North America Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 31. North America Immuno-oncology Therapy Sales Market Share by Country in 2023
Figure 32. U.S. Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 33. Canada Immuno-oncology Therapy Sales (K MT) and Growth Rate (2019-2025)
Figure 34. Mexico Immuno-oncology Therapy Sales (Units) and Growth Rate (2019-2025)
Figure 35. Europe Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 36. Europe Immuno-oncology Therapy Sales Market Share by Country in 2023
Figure 37. Germany Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 38. France Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 39. U.K. Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 40. Italy Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 41. Russia Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 42. Asia Pacific Immuno-oncology Therapy Sales and Growth Rate (K MT)
Figure 43. Asia Pacific Immuno-oncology Therapy Sales Market Share by Region in 2023
Figure 44. China Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 45. Japan Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 46. South Korea Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 47. India Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 48. Southeast Asia Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 49. South America Immuno-oncology Therapy Sales and Growth Rate (K MT)
Figure 50. South America Immuno-oncology Therapy Sales Market Share by Country in 2023
Figure 51. Brazil Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 52. Argentina Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 53. Columbia Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 54. Middle East and Africa Immuno-oncology Therapy Sales and Growth Rate (K MT)
Figure 55. Middle East and Africa Immuno-oncology Therapy Sales Market Share by Region in 2023
Figure 56. Saudi Arabia Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 57. UAE Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 58. Egypt Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 59. Nigeria Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 60. South Africa Immuno-oncology Therapy Sales and Growth Rate (2019-2025) & (K MT)
Figure 61. Global Immuno-oncology Therapy Production Market Share by Region (2019-2025)
Figure 62. North America Immuno-oncology Therapy Production (K MT) Growth Rate (2019-2025)
Figure 63. Europe Immuno-oncology Therapy Production (K MT) Growth Rate (2019-2025)
Figure 64. Japan Immuno-oncology Therapy Production (K MT) Growth Rate (2019-2025)
Figure 65. China Immuno-oncology Therapy Production (K MT) Growth Rate (2019-2025)
Figure 66. Global Immuno-oncology Therapy Sales Forecast by Volume (2019-2032) & (K MT)
Figure 67. Global Immuno-oncology Therapy Market Size Forecast by Value (2019-2032) & (M USD)
Figure 68. Global Immuno-oncology Therapy Sales Market Share Forecast by Type (2025-2032)
Figure 69. Global Immuno-oncology Therapy Market Share Forecast by Type (2025-2032)
Figure 70. Global Immuno-oncology Therapy Sales Forecast by Application (2025-2032)
Figure 71. Global Immuno-oncology Therapy Market Share Forecast by Application (2025-2032)
